ZIOPHARM ONCOLOGY INC 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 4, 2017
Insider Transaction Report
Form 4
BELBEL CAESAR J
EVP, Chief Legal Officer & Sec
Transactions
- Award
Common Stock
2016-12-30+94,350→ 211,884 total - Tax Payment
Common Stock
2016-12-31$5.35/sh−21,667$115,918→ 190,217 total
Footnotes (2)
- [F1]31,450 shares vest on each of 12/30/2017, 12/30/2018 and 12/30/2019.
- [F2]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.